Insight

Adrienne Bruce Shannon: dMMR gastroesophageal cancer treated with immunotherapy

Photo taken from Adrienne Bruce Shannon/X

Aug 26, 2024, 20:45

Adrienne Bruce Shannon: dMMR gastroesophageal cancer treated with immunotherapy

Adrienne Bruce Shannon, CGSO fellow at Moffitt Cancer Center, shared a post on X:

“proud to present our small but mighty Moffitt Cancer Center

experience with dMMR gastroesophageal cancer treated immunotherapy now in AnnalsSurgOncology.

Happy to add to the early literature on what will be practice-changing for this disease.”

Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein‑Deficient Gastroesophageal Cancers

Authors: Adrienne B Shannon, Rutika Mehta, Shaffer R Mok, Gregory Y Lauwers, Jobelle J A R Baldonado, Jacques Fontaine, Jose M Pimiento, and Andrew J Sinnamon

Source: Adrienne Bruce Shannon/X

Adrienne B Shannon Adrienne Bruce Shannon Andrew J Sinnamon cancer dMMR gastroesophageal cancer Gregory Y Lauwers immunotherapy Jacques Fontaine Jobelle J A R Baldonado Jose M Pimiento Moffitt Cancer Center OncoDaily Oncology Rutika Mehta Shaffer R Mok

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Writer?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...